NCT03359304View on ClinicalTrials.gov

The Neurofibromatosis-associated Tumor Biobank

Not yet recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2028

Conditions

Neurofibromatoses

All Listed Sponsors

lead

Ren tingting

OTHER

NCT03359304 - The Neurofibromatosis-associated Tumor Biobank | Biotech Hunter | Biotech Hunter